Background and aim: The war against Covid-19 is far from won. This narrative review attempts to describe some problems with the management of Covid-19 induced acute respiratory failure (ARF) by pulmonologists.
Methods: We searched the following databases: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and reviewed the references of retrieved articles for additional studies. The search was limited to the terms: Covid-19 AND: acute respiratory distress syndrome (ARDS), SARS, MERS, non invasive ventilation (NIV), high flow nasal cannula (HFNC), pronation (PP), health care workers (HCW).
Results: Protection of Health care workers should be paramount, so full Personal Protective Equipment and Negative pressure rooms are warranted. HFNC alone or with PP could be offered for mild cases (PaO2/FiO2 between 200-300); NIV alone or with PP may work in moderate cases (PaO2/FiO2 between 100-200). Rotation and coupled (HFNC/NIV) strategy can be beneficial. A window of opportunity of 1-2h is advised. If PaO2/FIO2 significantly increases, Respiratory Rate decreases with a relatively low Exhaled Tidal Volume, the non-invasive strategy could be working and intubation delayed.
Conclusion: Although there is a role for non-invasive respiratory therapies in the context of COVID-19 ARF, more research is still needed to define the balance of benefits and risks to patients and HCW. Indirectly, non invasive respiratory therapies may be of particular benefit in reducing the risks to healthcare workers by obviating the need for intubation, a potentially highly infectious procedure.
Keywords: Acute respiratory failure; Chest physiotherapy; Health care workers; High flow nasal cannula; Non invasive ventilation; Pronation.
Copyright © 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.
Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study.Crit Care. 2020 Jan 30;24(1):28. doi: 10.1186/s13054-020-2738-5. Crit Care. 2020. PMID: 32000806 Free PMC article.
High flow nasal cannula oxygen versus noninvasive ventilation in adult acute respiratory failure: a systematic review of randomized-controlled trials.Eur J Emerg Med. 2019 Feb;26(1):9-18. doi: 10.1097/MEJ.0000000000000557. Eur J Emerg Med. 2019. PMID: 29923842
High-flow oxygen via nasal cannulae in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis.Syst Rev. 2017 Oct 16;6(1):202. doi: 10.1186/s13643-017-0593-5. Syst Rev. 2017. PMID: 29037221 Free PMC article. Review.
Refractory Acute Respiratory Distress Syndrome Secondary to COVID-19 Successfully Extubated to Average Volume-assured Pressure Support Non-invasive Ventilator.Cureus. 2020 Apr 27;12(4):e7849. doi: 10.7759/cureus.7849. Cureus. 2020. PMID: 32483500 Free PMC article.
High-flow nasal cannulae for respiratory support in adult intensive care patients.Cochrane Database Syst Rev. 2017 May 30;5(5):CD010172. doi: 10.1002/14651858.CD010172.pub2. Cochrane Database Syst Rev. 2017. PMID: 28555461 Free PMC article. Review.